Boston Trust Walden’s Parexel International Corp PRXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-261,602
Closed -$22.7M 382
2017
Q2
$22.7M Sell
261,602
-52,483
-17% -$3.91M 0.37% 84
2017
Q1
$19.8M Sell
314,085
-23,181
-7% -$1.53M 0.31% 122
2016
Q4
$22.2M Buy
337,266
+129,010
+62% +$8.09M 0.35% 119
2016
Q3
$14.5M Buy
+208,256
New +$14.1M 0.24% 149

Other funds holding PRXL

Boston Trust Walden's PRXL Position: Q3 2017 in Review

Boston Trust Walden sold out of Parexel International Corp (PRXL) in Q3 2017, closing a stake of 261,602 shares — an estimated $22.7M sold.

Boston Trust Walden first reported a position in PRXL in Q3 2016 and held it in 4 quarters. The position peaked at $22.7M in Q2 2017. 246 funds tracked by Wall St. Rank hold PRXL as of Q3 2017.

  • Boston Trust Walden reported no remaining Parexel International Corp position as of Q3 2017 after selling out during the quarter.
  • Boston Trust Walden sold 261,602 Parexel International Corp shares in Q3 2017, an estimated $22.7M.
  • Boston Trust Walden first reported a position in Parexel International Corp in Q3 2016 and held it in 4 quarters.
  • Boston Trust Walden's Parexel International Corp position peaked at $22.7M in Q2 2017.
  • 246 funds tracked by Wall St. Rank held Parexel International Corp as of Q3 2017.

Based on Boston Trust Walden's 13F filing for Q3 2017, filed 13 Oct 2017.